By checking stability of implant and bone density around implant this study will be comparing two growth factors namely concentrated growth factor and injectable platelet rich fibrin when mixed with bone graft and used in maxillary sinus floor lifting procedure during implant surgery

Phase 3

Completed

• Conditions: Health Condition 1: K082- Atrophy of edentulous alveolar ridge

• Registration Number: CTRI/2023/08/057033
• Lead Sponsor: Dr Unnati Agarwal

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-03-29
• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

1.Patients willing for voluntary participation & have signed informed consent for the described procedure.

2.Patients having good physical and mental health and well-formed or moderately formed residual alveolar ridge

3.Systemically healthy subjects.

4.Patients requiring Sinus augmentation prior to placement of implant.

5.Patients well motivated for implant therapy and maintaining good oral hygiene.

6.Patients requiring bilateral sinus lift

Exclusion Criteria

1.Immunocompromised patients.

2.Grafted site (previous or during implant placement).

3.Patients of chronic and aggressive periodontitis.

4.Flapless procedures.

5.Alcohol or drug abuse.

6.Psychologically compromised patients.

7.Patients with temporomandibular disorders, severe residual ridge resorption, orofacial tumors and gross facial deformity, mucositis, radiation therapy, parafunctional habit, etc.

8.Patients with active diseases of the implant bed (e.g., residual cysts)

9.Cancer Patients (ongoing chemotherapy)

10.Patients on steroid therapy

11.Severe Metabolic Diseases

12.Immunocompromised patients

13.Abnormal Platelet Function

14.Bisphosphonates Therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified